201 related articles for article (PubMed ID: 34958113)
1. Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression
Joo M; Heo JB; Kim S; Kim N; Jeon HJ; An Y; Song GY; Kim JM; Lee HJ
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958113
[TBL] [Abstract][Full Text] [Related]
2. Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.
Kim S; Kim JE; Kim N; Joo M; Lee MW; Jeon HJ; Ryu H; Song IC; Song GY; Lee HJ
Am J Cancer Res; 2019; 9(9):2007-2018. PubMed ID: 31598401
[TBL] [Abstract][Full Text] [Related]
3. CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling.
Kim N; Ryu H; Kim S; Joo M; Jeon HJ; Lee MW; Song IC; Kim MN; Kim JM; Lee HJ
Sci Rep; 2019 Dec; 9(1):18100. PubMed ID: 31792315
[TBL] [Abstract][Full Text] [Related]
4. Decursin inhibits growth of human bladder and colon cancer cells via apoptosis, G1-phase cell cycle arrest and extracellular signal-regulated kinase activation.
Kim WJ; Lee SJ; Choi YD; Moon SK
Int J Mol Med; 2010 Apr; 25(4):635-41. PubMed ID: 20198313
[TBL] [Abstract][Full Text] [Related]
5. Effect of
Kweon B; Han YH; Kee JY; Mun JG; Jeon HD; Yoon DH; Choi BM; Hong SH
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349276
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Antiproliferative Activity and Molecular Docking Analysis of Both Enantiomerically Pure Decursin Derivatives as Anticancer Agents.
Ahn J; Hwang HH; Jung SY; Lee JY; Kim C; Choi HM; Gwon MJ; Kim MJ; Kwon Y; Woo J; Park B; Ko SG; Lee JY
Chem Pharm Bull (Tokyo); 2024 May; 72(5):498-506. PubMed ID: 38735699
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63‑mediated tight junction molecules and p21‑mediated growth arrest.
Kakiuchi A; Kakuki T; Ohwada K; Kurose M; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Himi T; Takano KI; Kojima T
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649777
[TBL] [Abstract][Full Text] [Related]
8. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
9. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway.
Li N; Xu H; Ou Y; Feng Z; Zhang Q; Zhu Q; Cai Z
Diagn Pathol; 2019 Jan; 14(1):3. PubMed ID: 30636642
[TBL] [Abstract][Full Text] [Related]
10. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma.
Son SH; Park KK; Park SK; Kim YC; Kim YS; Lee SK; Chung WY
Phytother Res; 2011 Jul; 25(7):959-64. PubMed ID: 21170925
[TBL] [Abstract][Full Text] [Related]
11. Erchen decoction plus huiyanzhuyu decoction inhibits the cell cycle, migration and invasion and induces the apoptosis of laryngeal squamous cell carcinoma cells.
Zhou S; Luo Q; Tan X; Huang W; Feng X; Zhang T; Chen W; Yang C; Li Y
J Ethnopharmacol; 2020 Jun; 256():112638. PubMed ID: 32007633
[TBL] [Abstract][Full Text] [Related]
12. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
[TBL] [Abstract][Full Text] [Related]
13. Decursin prevents TPA-induced invasion through suppression of PKCα/p38/NF-κB-dependent MMP-9 expression in MCF-7 human breast carcinoma cells.
Kim JM; Noh EM; Kim MS; Hwang JK; Hwang HY; Ryu DG; Kim HJ; Yu HN; You YO; Kim JS; Youn HJ; Kwon KB; Jung SH; Lee YR
Int J Oncol; 2014 May; 44(5):1607-13. PubMed ID: 24604087
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
15. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
Kim JH; Jung JH; Kim SH; Jeong SJ
Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
[TBL] [Abstract][Full Text] [Related]
16. Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21.
Wu H; Pang P; Liu MD; Wang S; Jin S; Liu FY; Sun CF
Oncol Rep; 2018 Aug; 40(2):1138-1146. PubMed ID: 29901115
[TBL] [Abstract][Full Text] [Related]
17. Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.
Maussang D; Mujić-Delić A; Descamps FJ; Stortelers C; Vanlandschoot P; Stigter-van Walsum M; Vischer HF; van Roy M; Vosjan M; Gonzalez-Pajuelo M; van Dongen GA; Merchiers P; van Rompaey P; Smit MJ
J Biol Chem; 2013 Oct; 288(41):29562-72. PubMed ID: 23979133
[TBL] [Abstract][Full Text] [Related]
18. [Expression of integrin αvβ3, CXC chemokine receptor 4 and CXC chemokine receptor 7 and their relationship with lymph node metastasis in squamous cell carcinoma of head and neck].
Li P; Li WL; Qi JX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Dec; 52(12):723-729. PubMed ID: 29275565
[No Abstract] [Full Text] [Related]
19. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
20. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
